Fluoxetine Hydrochloride

Verify with FDA CVM →

496 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
496
Total Reports
15
Deaths Reported
300.0%
Death Rate

Active Ingredients

Fluoxetine Hydrochloride

Administration Routes

OralUnknownIntraocular

Species Affected

Dog 421
Unknown 40
Cat 35

Most Affected Breeds

Unknown 40
Retriever - Labrador 28
Crossbred Canine/dog 23
Shepherd Dog - German 20
Domestic Shorthair 18
Shih Tzu 18
Dog (unknown) 17
Dog (other) 16
Terrier - Yorkshire 16
Chihuahua 15

Most Reported Reactions

Lack of efficacy - NOS 114
Vomiting 55
Behavioural disorder NOS 48
Decreased appetite 47
Lethargy (see also Central nervous system depression in Neurological) 40
Tablets, Abnormal 37
Anxiety 37
Seizure NOS 30
Anorexia 30
Diarrhoea 28
Emesis 24
Panting 24

Outcome Breakdown

Outcome Unknown
149 (32.7%)
Recovered/Normal
147 (32.2%)
Recovered with Sequela
84 (18.4%)
Ongoing
61 (13.4%)
Euthanized
9 (2.0%)
Died
6 (1.3%)

Data Summary

Metric Value
Total adverse event reports 496
Reports involving death 15
Case-fatality rate (reported events) 300.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Fluoxetine Hydrochloride Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 496 adverse event reports referencing Fluoxetine Hydrochloride, including 15 reports in which the animal died — a 300.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Fluoxetine Hydrochloride. Reported administration routes include Oral, Unknown, Intraocular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Fluoxetine Hydrochloride reports are Dog (421 reports), Unknown (40 reports), Cat (35 reports), with Dog accounting for the largest share. Within those species, Unknown (40), Retriever - Labrador (28), Crossbred Canine/dog (23) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Fluoxetine Hydrochloride are Lack of efficacy - NOS (114), Vomiting (55), Behavioural disorder NOS (48), Decreased appetite (47). Of the 456 reports with a coded outcome, Outcome Unknown is the leading category at 32.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Fluoxetine Hydrochloride.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial